Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Mar 2026 for Maxcyte, INC.. Read the official filing
Filing timeline
BuySaleMaher Masoud
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+12.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Maher Masoud: trading record in brief
All filings by Maher Masoud on record concern Maxcyte, Inc., in the capacity of board member. The record holds 4 filings, for trades running from 12 November 2021 to 27 March 2026.
Purchases make up the whole of the open-market record (2 purchases, €220k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant and 1 option exercise.
The newest entry dates from 31 March 2026: a share grant, in Maxcyte, Inc. The last insider purchase was made public on 13 August 2025, 431 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Maher Masoud
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
300,000 shares0Common StockSEC:0000905148-26-001480:0
75,000 shares@ US$1.372233.0% of flowCommon StockSEC:0000905148-25-002876:0
Canonical exit: 11 Nov 2025 (T+90)
29,557 shares@ US$4.86658.6% of flowCommon StockSEC:0001415889-24-016259:0
Canonical exit: 5 Sept 2024 (T+90)
25,722 shares@ US$2.0817.5% of flowCommon StockSEC:0001209191-21-064891:0
4 of 4 declarations
